This paper is in the following e-collection/theme issue:

Viewpoints and Perspectives (521) New Methods (955) Tools, Programs and Algorithms (272)

Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43484, first published .
Data Challenges for Externally Controlled Trials: Viewpoint

Data Challenges for Externally Controlled Trials: Viewpoint

Data Challenges for Externally Controlled Trials: Viewpoint

Authors of this article:

Russanthy Ruthiran Velummailum1 Author Orcid Image ;   Chelsea McKibbon1 Author Orcid Image ;   Darren R Brenner2 Author Orcid Image ;   Elizabeth Ann Stringer3 Author Orcid Image ;   Leeland Ekstrom3 Author Orcid Image ;   Louis Dron1 Author Orcid Image
Article Authors Cited by (4) Tweetations (3) Metrics

Journals

  1. Luu V, Fiorini M, Combes S, Quemeneur E, Bonneville M, Bousquet P. Challenges of artificial intelligence in precision oncology: public-private partnerships including national health agencies as an asset to make it happen. Annals of Oncology 2024;35(2):154 View
  2. Struebing A, McKibbon C, Ruan H, Mackay E, Dennis N, Velummailum R, He P, Tanaka Y, Xiong Y, Springford A, Rosenlund M. Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer. Journal of Comparative Effectiveness Research 2024;13(5) View
  3. Farah E, Kenney M, Warkentin M, Cheung W, Brenner D. Examining external control arms in oncology: A scoping review of applications to date. Cancer Medicine 2024;13(13) View
  4. Janda G, Jeffery M, Ramachandran R, Ross J, Wallach J. Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional study. BMC Medical Research Methodology 2024;24(1) View